Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Defence Therapeutics Inc (DTCFF)

Defence Therapeutics Inc (DTCFF)
0.6447 -0.3517 (-35.30%) 04/10/25 [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.6447
Day High
0.6447
Open 0.6447
Previous Close 0.9964 0.9964
Volume 400 400
Avg Vol 20,470 20,470
Stochastic %K 66.54% 66.54%
Weighted Alpha -36.73 -36.73
5-Day Change -0.1446 (-18.32%) -0.1446 (-18.32%)
52-Week Range 0.2732 - 1.1575 0.2732 - 1.1575
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6447 unch
on 04/10/25
Period Open: 0.9286
0.9964 -35.30%
on 03/11/25
-0.2839 (-30.57%)
since 03/07/25
3-Month
0.4150 +55.35%
on 01/16/25
Period Open: 0.4500
1.1575 -44.30%
on 02/20/25
+0.1947 (+43.27%)
since 01/08/25
52-Week
0.2732 +135.98%
on 12/17/24
Period Open: 1.0200
1.1575 -44.30%
on 02/20/25
-0.3753 (-36.79%)
since 04/10/24

Most Recent Stories

More News
Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies

Montreal, Quebec--(Newsfile Corp. - April 8, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing advanced...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.9300 (+3.33%)
Defence Announces US Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Defence's Management Team as Chief Operating Officer

Montreal, Quebec--(Newsfile Corp. - March 26, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.9300 (+3.33%)
Defence Closes Second Tranche of Fully Subscribed Financing Totaling $4.2 Million

Montreal, Quebec--(Newsfile Corp. - January 31, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.9300 (+3.33%)
Defence to Connect with Industry Leaders and Potential Partners During the JP Morgan Healthcare Conference in San Francisco. Plans to Expand the Next Generation of Radio-Immuno Conjugates in 2025

Montreal, Quebec--(Newsfile Corp. - January 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company") a Canadian biopharmaceutical company developing radiopharmaceuticals...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.9300 (+3.33%)
Defence Fortifies Patent Portfolio

Vancouver, British Columbia--(Newsfile Corp. - January 6, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.9300 (+3.33%)
Defence Arranges Financing

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.9300 (+3.33%)
Defence Announces Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Its Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - December 20, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.9300 (+3.33%)
Defence Provides Update on Delivery of AGSM Proxy Materials

Vancouver, British Columbia--(Newsfile Corp. - December 2, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.9300 (+3.33%)
Defence's Proprietary Accum Technology Ready to License to Companies Developing Antibody Drug Conjugates (ADC)

Vancouver, British Columbia--(Newsfile Corp. - November 29, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.9300 (+3.33%)
Defence Announces Dr. Maxime Parisotto as CSO, Director of Science and Business Development

Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing...

DTCFF : 0.6447 (-35.30%)
DTC.CN : 0.9300 (+3.33%)

Key Turning Points

3rd Resistance Point 0.6447
2nd Resistance Point 0.6447
1st Resistance Point 0.6447
Last Price 0.6447
1st Support Level 0.6447
2nd Support Level 0.6447
3rd Support Level 0.6447

See More

52-Week High 1.1575
Fibonacci 61.8% 0.8197
Fibonacci 50% 0.7154
Last Price 0.6447
Fibonacci 38.2% 0.6110
52-Week Low 0.2732

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar